Literature DB >> 8823780

Chemotherapy of cerebral metastases from solid tumors.

G J Lesser1.   

Abstract

With proper staging, patients with parenchymal brain metastases from solid tumors are usually found to have widespread extracranial disease. Systemic chemotherapy offers the potential advantage of simultaneous therapy of both intracranial and extracranial tumor. Limited data is available on the efficacy of drug therapy alone in this patient population for selected patients with chemosensitive malignancies and brain metastases, systemic chemotherapy administration represents a useful treatment modality when given at presentation or following recurrence after surgery or radiation therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823780

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  13 in total

Review 1.  Radiotherapy and chemotherapy of brain metastases.

Authors:  R Soffietti; A Costanza; E Laguzzi; M Nobile; R Rudà
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

Review 2.  Brain metastasis: new opportunities to tackle therapeutic resistance.

Authors:  Joan Seoane; Leticia De Mattos-Arruda
Journal:  Mol Oncol       Date:  2014-06-02       Impact factor: 6.603

3.  A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.

Authors:  L E Abrey; J D Olson; J J Raizer; M Mack; A Rodavitch; D Y Boutros; M G Malkin
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

Review 4.  Chemotherapy for metastatic tumors to the central nervous system.

Authors:  C A Conrad
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

Review 5.  Systemic therapy for brain metastases.

Authors:  Jonathan W Rick; Maryam Shahin; Ankush Chandra; Cecilia Dalle Ore; John K Yue; Alan Nguyen; Garima Yagnik; Soumya Sagar; Saman Arfaie; Manish K Aghi
Journal:  Crit Rev Oncol Hematol       Date:  2019-07-22       Impact factor: 6.312

6.  Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib.

Authors:  Mitsuaki Sakai; Shigemi Ishikawa; Hiromichi Ito; Yuichiro Ozawa; Tatsuo Yamamoto; Masataka Onizuka; Yuzuru Sakakibara
Journal:  Int J Clin Oncol       Date:  2006-06       Impact factor: 3.402

7.  Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors.

Authors:  Herbert B Newton; Mary A Slivka; Carol Volpi; Eric C Bourekas; Gregory A Christoforidis; Melissa A Baujan; Wayne Slone; Donald W Chakeres
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

8.  Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report.

Authors:  H B Newton; C Stevens; M Santi
Journal:  J Neurooncol       Date:  2001-12       Impact factor: 4.130

Review 9.  Revisiting the role of molecular targeted therapies in patients with brain metastases.

Authors:  Dionysis Papadatos-Pastos; Udai Banerji
Journal:  J Neurooncol       Date:  2011-07-22       Impact factor: 4.130

Review 10.  Brain metastases.

Authors:  P Y Wen; J S Loeffler
Journal:  Curr Treat Options Oncol       Date:  2000-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.